MedPath

Inmagene Biopharmaceuticals Limited

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

PPB:2

Drug Approvals

TAVALISSE TABLETS 100MG

Approval Date
Oct 28, 2022
PPB

TAVALISSE TABLETS 150MG

Approval Date
Oct 28, 2022
PPB

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.